Wu Meilong, Yang Shizhong, Feng Xiaobin, Yu Fei, Liu Xiangchen, Dong Jiahong
School of Clinical Medicine, Tsinghua University, Haidian, Beijing 100084, P.R. China.
Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Changping, Beijing 102218, P.R. China.
Oncol Lett. 2020 Dec;20(6):375. doi: 10.3892/ol.2020.12238. Epub 2020 Oct 21.
The preoperative neutrophil-lymphocyte ratio (NLR) and the postoperative NLR have been reported to be prognostic factors for malignant tumors. However, the prognostic value of combining the preoperative NLR and postoperative NLR for hepatocellular carcinoma (HCC) remains unclear. In the present study, a cohort of 70 patients with primary HCC were retrospectively reviewed. The optimal cut-offs for continuous variables were determined by the maximally selected rank statistics. The prognostic factors included preoperative NLR, postoperative NLR, preoperative NLR plus postoperative NLR, change in postoperative NLR, and postoperative NLR minus preoperative NLR. The predictive powers of the aforementioned prognostic factors were analyzed by the area under the time-dependent receiver operating characteristic (td-AUC) curve. Prognostic values were assessed by univariate and multivariate analyses. An increased preoperative NLR was found to be associated with higher preoperative neutrophil levels, lower preoperative lymphocyte levels and larger tumor sizes (all P<0.05). An increased postoperative NLR was associated with higher postoperative neutrophil levels and lower postoperative lymphocyte levels (all P<0.05). Multivariate analysis identified the preoperative NLR plus postoperative NLR as an independent prognostic risk factor (HR, 2.985; 95% CI, 1.648-5.407; P<0.001). The preoperative NLR plus postoperative NLR had higher td-AUC values than the preoperative NLR, postoperative NLR, postoperative NLR change, and postoperative NLR minus the preoperative NLR in the first to fourth years after surgery. The preoperative NLR plus postoperative NLR, considering both the preoperative and postoperative treatment phases, is a novel and promising prognostic factor for patients with HCC and requires further investigation in the future.
术前中性粒细胞与淋巴细胞比值(NLR)和术后NLR已被报道为恶性肿瘤的预后因素。然而,术前NLR与术后NLR联合对肝细胞癌(HCC)的预后价值仍不清楚。在本研究中,回顾性分析了70例原发性HCC患者的队列。连续变量的最佳截断值通过最大选择秩统计量确定。预后因素包括术前NLR、术后NLR、术前NLR加术后NLR、术后NLR变化以及术后NLR减去术前NLR。通过时间依赖性受试者工作特征(td-AUC)曲线下面积分析上述预后因素的预测能力。通过单因素和多因素分析评估预后价值。发现术前NLR升高与术前中性粒细胞水平升高、术前淋巴细胞水平降低和肿瘤较大有关(均P<0.05)。术后NLR升高与术后中性粒细胞水平升高和术后淋巴细胞水平降低有关(均P<0.05)。多因素分析确定术前NLR加术后NLR为独立的预后危险因素(HR,2.985;95%CI,1.648-5.407;P<0.001)。在术后第一至四年,术前NLR加术后NLR的td-AUC值高于术前NLR、术后NLR、术后NLR变化以及术后NLR减去术前NLR。术前NLR加术后NLR,考虑到术前和术后治疗阶段,是HCC患者一种新的且有前景的预后因素,未来需要进一步研究。